tiprankstipranks
Autolus Therapeutics (DE:6A3A)
NASDAQ:6A3A
Germany Market
6A3A
Autolus Therapeutics
RESEARCH TOOLSreports

Autolus Therapeutics (6A3A) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

6A3A Analyst Ratings

Strong Buy
6Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Autolus
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

6A3A Stock 12 Month Forecast

Average Price Target

€7.02
▲(431.77% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Autolus Therapeutics in the last 3 months. The average price target is €7.02 with a high forecast of €8.69 and a low forecast of €4.34. The average price target represents a 431.77% change from the last price of €1.32.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","9":"€9","2.25":"€2.25","4.5":"€4.5","6.75":"€6.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":8.6874029,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€8.69</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.0194215432,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€7.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.34370145,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€4.34</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.25,4.5,6.75,9],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.32,1.8867233,2.4534466000000004,3.0201699,3.5868932000000004,4.1536165,4.7203398000000005,5.2870631,5.853786400000001,6.4205097,6.987233000000001,7.553956300000001,8.1206796,{"y":8.6874029,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.32,1.7584170417846154,2.1968340835692306,2.635251125353846,3.073668167138462,3.512085208923077,3.950502250707692,4.388919292492308,4.827336334276923,5.2657533760615385,5.704170417846154,6.14258745963077,6.581004501415385,{"y":7.0194215432,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.32,1.5525924192307694,1.7851848384615385,2.0177772576923076,2.2503696769230768,2.4829620961538463,2.7155545153846155,2.9481469346153846,3.180739353846154,3.413331773076923,3.6459241923076924,3.878516611538462,4.111109030769231,{"y":4.34370145,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.08,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.26,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.38,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.3,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.24,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.62,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.16,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.44,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.19,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.19,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.59,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.38,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.32,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€8.69Average Price Target€7.02Lowest Price Target€4.34
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:6A3A
Emily Bodnar
H.C. Wainwright
H.C. Wainwright
€8.69
Buy
558.14%
Upside
Reiterated
07/13/26
Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF)
Mizuho Securities Analyst forecast on DE:6A3A
Salim Syed
Mizuho Securities
Mizuho Securities
€8.69
Buy
558.14%
Upside
Reiterated
06/10/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Autolus Therapeutics (NASDAQ: AUTL), Galmed Pharmaceuticals (NASDAQ: GLMD) and Oculis Holding (NASDAQ: OCS)
William Blair Analyst forecast on DE:6A3A
Matt Phipps
William Blair
William Blair
―
Buy
―
Reiterated
06/02/26
Analysts Are Bullish on Top Healthcare Stocks: Autolus Therapeutics (AUTL), Wuxi Biologics (Cayman) (WXIBF)
Wells Fargo Analyst forecast on DE:6A3A
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
€4.34
Buy
229.07%
Upside
Reiterated
05/15/26
Wells Fargo Remains a Buy on Autolus Therapeutics (AUTL)
Goldman Sachs Analyst forecast on DE:6A3A
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
€5.3→€4.69
Buy
255.39%
Upside
Assigned
05/15/26
Goldman Sachs Sticks to Their Buy Rating for Autolus Therapeutics (AUTL)
Needham Analyst forecast on DE:6A3A
Gil Blum
Needham
Needham
€8.69
Buy
558.14%
Upside
Reiterated
05/14/26
Autolus Therapeutics: Buy Rating Reiterated as Aucatzyl Momentum Builds and Pipeline Advances; $10 Price Target Maintained
Truist Financial Analyst forecast on DE:6A3A
Asthika Goonewardene
Truist Financial
Truist Financial
€8.69→€6.95
Buy
426.51%
Upside
Reiterated
01/13/26
Truist Financial Sticks to Its Buy Rating for Autolus Therapeutics (AUTL)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:6A3A
Emily Bodnar
H.C. Wainwright
H.C. Wainwright
€8.69
Buy
558.14%
Upside
Reiterated
07/13/26
Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF)
Mizuho Securities Analyst forecast on DE:6A3A
Salim Syed
Mizuho Securities
Mizuho Securities
€8.69
Buy
558.14%
Upside
Reiterated
06/10/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Autolus Therapeutics (NASDAQ: AUTL), Galmed Pharmaceuticals (NASDAQ: GLMD) and Oculis Holding (NASDAQ: OCS)
William Blair Analyst forecast on DE:6A3A
Matt Phipps
William Blair
William Blair
―
Buy
―
Reiterated
06/02/26
Analysts Are Bullish on Top Healthcare Stocks: Autolus Therapeutics (AUTL), Wuxi Biologics (Cayman) (WXIBF)
Wells Fargo Analyst forecast on DE:6A3A
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
€4.34
Buy
229.07%
Upside
Reiterated
05/15/26
Wells Fargo Remains a Buy on Autolus Therapeutics (AUTL)
Goldman Sachs Analyst forecast on DE:6A3A
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
€5.3→€4.69
Buy
255.39%
Upside
Assigned
05/15/26
Goldman Sachs Sticks to Their Buy Rating for Autolus Therapeutics (AUTL)
Needham Analyst forecast on DE:6A3A
Gil Blum
Needham
Needham
€8.69
Buy
558.14%
Upside
Reiterated
05/14/26
Autolus Therapeutics: Buy Rating Reiterated as Aucatzyl Momentum Builds and Pipeline Advances; $10 Price Target Maintained
Truist Financial Analyst forecast on DE:6A3A
Asthika Goonewardene
Truist Financial
Truist Financial
€8.69→€6.95
Buy
426.51%
Upside
Reiterated
01/13/26
Truist Financial Sticks to Its Buy Rating for Autolus Therapeutics (AUTL)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Autolus Therapeutics

3 Months
Gil BlumNeedham
Success Rate
14/33 ratings generated profit
42%
Average Return
+4.34%
Copying Gil Blum's trades and holding each position for 3 Months would result in 42.42% of your transactions generating a profit, with an average return of +4.34% per trade.
1 Year
Gil BlumNeedham
Success Rate
13/33 ratings generated profit
39%
Average Return
+1.22%
Copying Gil Blum's trades and holding each position for 1 Year would result in 39.39% of your transactions generating a profit, with an average return of +1.22% per trade.
2 Years
Asthika GoonewardeneTruist Financial
Success Rate
7/22 ratings generated profit
32%
Average Return
-24.34%
Copying Asthika Goonewardene's trades and holding each position for 2 Years would result in 31.82% of your transactions generating a profit, with an average return of -24.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6A3A Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
8
10
9
6
2
Buy
2
3
3
2
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
13
12
8
3
In the current month, 6A3A has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 6A3A average Analyst price target in the past 3 months is 7.02.
Each month's total comprises the sum of three months' worth of ratings.

6A3A Financial Forecast

6A3A Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

6A3A Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

6A3A Stock Forecast FAQ

What is DE:6A3A’s average 12-month price target, according to analysts?
Based on analyst ratings, Autolus Therapeutics’s 12-month average price target is 7.02.
    What is DE:6A3A’s upside potential, based on the analysts’ average price target?
    Autolus Therapeutics has 431.77% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Autolus Therapeutics a Buy, Sell or Hold?
          Autolus Therapeutics has a consensus rating of Strong Buy, which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Autolus Therapeutics’s share price target?
            The average share price target for Autolus Therapeutics is 7.02. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €8.69 ,and the lowest forecast is €4.34. The average share price target represents 431.77% Increase from the current price of €1.32.
              What do analysts say about Autolus Therapeutics?
              Autolus Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of Autolus Therapeutics?
                To buy shares of DE:6A3A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.